VVOS
Vivos Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.11
+1.39%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$0.11
From 52W high−95.76%
Volume438725.00
Market cap$3.69M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataNov 3, 2026
Open
$0.11
From 52W high
−95.76%
Volume
438725.00
Market cap
$3.69M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
P/E (TTM)
—
RSI (14)
28.2
MomentumView details →
1D Return
+1.39%
YTD Return
−94.54%
SummaryUpdated Jun 1, 2026
Vivos Therapeutics, Inc. (NASDAQ:VVOS) is a medical technology company founded in 2016 and based in Highlands Ranch, Colorado. The company went public in December 2020 and specializes in developing non-invasive treatment alternatives for patients suffering from dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. Vivos has undergone significant strategic transformation since its founding, evolving from a dental-focused distribution model to a medical sleep center partnership approach, while maintaining its core focus on providing alternatives to traditional CPAP therapy for sleep apnea patients.
Similar companies
Latest newsMore news →
Vivos Therapeutics issued 12,000 shares of Series C Convertible Preferred Stock valued at $12 million to SOD Sciences in exchange for 2,907,338 SOD common shares and a 50% interest in the Test and related intellectual property.20d agoVivos Therapeutics, Inc. dismissed Baker Tilly US, LLP as its independent auditor and engaged Haynie & Company as its new independent auditor, effective September 29, 2026.34d ago